Portfolio company
Oppilotech
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company provides biochemical modelling services and predictive computational platforms to help pharmaceutical and biotechnology organisations identify drug targets and develop antibacterial compounds.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
MetalloBio
This company develops antimicrobial compounds and medical device coatings to combat antibiotic resistance for the pharmaceutical and healthcare sectors.
MendelFOLD
This company develops computational protein modelling tools to help pharmaceutical teams and researchers identify drug binding sites and design new medical treatments.
Nexilico
This company develops a computational discovery platform for precision microbiome engineering to help pharmaceutical firms and healthcare providers design targeted therapies and personalised treatments.
Oxford Drug Design
This company develops novel cancer and antibiotic therapeutics for the healthcare industry using a proprietary artificial intelligence and machine learning drug discovery platform.
Discuva
This biotechnology company develops novel antibiotics to treat multi-drug resistant bacterial infections for pharmaceutical partners and healthcare providers.
PolyModels Hub
This company develops a digital platform for biopharma process development to help scientists design, simulate and optimise pharmaceutical manufacturing workflows.
Applied BioMath
The company develops biosimulation software and mathematical modeling platforms to support drug discovery and development for biotechnology and pharmaceutical organisations.
Avicenna Biosciences
The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.
